title: Reply to comments on "evaluation of dabigatran exposures reported to poison centers".
authors.affiliation: The University of Oklahoma College of Pharmacy, Oklahoma City, OK, USA.
authors.forename: Donald L
authors.initials: DL
authors.lastname: Harrison
authors.forename: Scott E
authors.initials: SE
authors.lastname: Schaeffer
authors.forename: Susan E
authors.initials: SE
authors.lastname: Conway
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects*; D001562:Benzimidazoles / Q000009:adverse effects*; D000069604:Dabigatran; D005260:Female; D006801:Humans; D008297:Male; D011039:Poison Control Centers; D015091:beta-Alanine / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D000925:Anticoagulants; D001562:Benzimidazoles; D015091:beta-Alanine; D000069604:Dabigatran